Equities

LTR Pharma Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

LTR Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.590
  • Today's Change0.10 / 20.41%
  • Shares traded355.29k
  • 1 Year change-13.87%
  • Beta--
Data delayed at least 20 minutes, as of Feb 10 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is developing and commercializing therapies that address significant unmet medical needs. The Company is focused on improving men’s health through clinical development and commercialization of nasal spray treatments for erectile dysfunction. Its lead products, SPONTAN and ROXUS, are fast-acting intranasal sprays for the treatment of erectile dysfunction, enabling onset of action in 10 minutes or less. The Company is also advancing OROFLOW, a novel intranasal spray under development for the treatment of Oesophageal Motility Disorders (OMD) - a debilitating group of conditions affecting swallowing function. The Company's subsidiary is LTR Pharma Inc.

  • Revenue in AUD (TTM)2.10m
  • Net income in AUD-5.59m
  • Incorporated2020
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Entropy Neurodynamics Ltd1.59m-5.33m50.05m----7.72--31.53-0.0043-0.00430.00120.00410.2249--0.763---75.55---92.06-------335.91-----100.790.00-----10.25-----26.73--
Syntara Ltd7.48m-12.26m57.16m107.00--3.55--7.64-0.0084-0.00540.00510.00990.4701--2.53---77.03-36.39-116.54-50.26-----163.86-78.37---953.380.0052--37.80-9.8310.31------
Amplia Therapeutics Ltd5.01m-7.93m59.00m1.00--1.37--11.78-0.0204-0.02040.01280.08370.1705--1.28---27.01-27.37-28.31-30.38-----158.46-180.53----0.0088---15.01156.11-45.93------
Clever Culture Systems Ltd6.52m1.68m60.84m17.0035.908.7631.879.330.00080.00080.00310.00320.69750.98296.37--18.01-36.7322.73-42.0077.05--25.82-281.211.63--0.2653--397.8630.08145.03--24.71--
Proteomics International LaboratoriesLtd3.31m-8.11m76.81m----5.77--23.19-0.0605-0.06050.02470.08050.2582--12.02---63.57-63.62-68.88-71.91-----246.18-222.10----0.021--1.3415.81-27.27---54.88--
Prescient Therapeutics Ltd225.61k-7.32m78.86m3.00--5.30--349.56-0.0091-0.00910.00030.01410.0129--0.9582---41.90-31.70-49.69-34.33-----3,245.66-2,146.75---590.480.00---67.1926.2411.11------
Imugene Ltd0.00-69.02m80.38m0.00--1.22-----0.3161-0.31610.000.2050.00-------58.75-48.72-75.21-53.73------------0.1913------53.89--38.40--
Rhythm Biosciences Ltd3.33m-3.83m83.40m----112.19--25.08-0.0134-0.01340.01240.00231.5398.7967.11---176.04-146.24-469.96-197.40-10.4422.48-115.14-287.420.8046-53.890.6266--90.87135.1444.15---12.61--
LTR Pharma Ltd2.10m-5.59m89.05m----2.81--42.33-0.0333-0.03330.01260.17410.1183--8.22---31.44---32.47-------265.90--45.76-62.540.00--4,164.38--19.57------
Cynata Therapeutics Ltd227.70k-9.39m90.23m0.00--14.35--396.28-0.0453-0.04530.00110.02650.0292--2.16---120.50-48.36-142.29-53.09-----4,124.10-576.20---1,268.000.00---45.4928.123.63------
Bioxyne Ltd28.43m4.90m94.08m16.0018.107.3316.543.310.00230.00230.01320.00572.166.3017.06--37.31-28.1755.76-38.1636.3235.9717.24-24.141.90--0.1125--204.8765.94138.29--127.89--
Alterity Therapeutics Ltd446.29k-12.15m97.88m9.00--1.94--219.32-0.002-0.0020.000070.00470.0137--5,578.6349,587.78-37.23-49.00-43.12-57.35-----2,721.96-9,708.51---211.820.0037--66.2791.9736.48------
Tetratherix Ltd1.14m-9.43m103.00m----7.00--90.14-0.1873-0.18730.02270.54140.0688--2.22---56.71---76.72---172.06---824.89-----98.750.0697--32.30---269.05------
Island Pharmaceuticals Ltd58.80k-3.92m113.00m----13.86--1,921.80-0.0224-0.02240.00030.03030.0117--0.1099---77.95-72.12-90.37-81.53-----6,666.91-19,239.15---162.890.00--1,148.41---36.86------
Arovella Therapeutics Ltd525.53k-7.51m118.92m14.00--5.86--226.28-0.0067-0.00670.00050.01690.0301-------43.05-75.94-47.90-90.89-----1,428.87-2,386.13----0.00--237.44-1.8214.14--1.23--
Data as of Feb 10 2026. Currency figures normalised to LTR Pharma Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.